Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne C Koff

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Expert Review of Vaccines|April 25, 2017
A bioinformatics roadmap for the human vaccines projectRichard H Scheuermann, Robert S Sinkovits, Theodore Schenkelberg, et al.
Expert Review of Vaccines|February 13, 2015
Building the Human Vaccines Project: strategic management recommendations and summary report of the 15-16 July 2014 business workshopTheodore Schenkelberg, Marie-Paule Kieny, A E Bianco, et al.
Lancet (London, England)|November 30, 2004
An AIDS vaccine: no time to give upDennis R Burton, Ronald C Desrosiers, Philip R Johnson, et al.
Nature Medicine|June 7, 2008
Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humansDavid I Watkins, Dennis R Burton, Esper G Kallas, et al.
Retrovirology|November 23, 2016
Membrane bound modified form of clade B Env, JRCSF is suitable for immunogen design as it is efficiently cleaved and displays all the broadly neutralizing epitopes including V2 and C2 domain-dependent conformational epitopesSupratik Das, Saikat Boliar, Nivedita Mitra, et al.
Vaccine|March 20, 2016
Status of vaccine research and development of vaccines for HIV-1Jeffrey T Safrit, Patricia E Fast, Lisa Gieber, et al.
Scientific Reports|October 28, 2014
Toward a more accurate view of human B-cell repertoire by next-generation sequencing, unbiased repertoire capture and single-molecule barcodingLinling He, Devin Sok, Parisa Azadnia, et al.
Nature Chemical Biology|July 9, 2013
Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodiesMohammed N Amin, Jason S McLellan, Wei Huang, et al.
Trends in Immunology|April 29, 2020
Improving Vaccine-Induced Immunity: Can Baseline Predict Outcome?John S Tsang, Carlota Dobaño, Pierre VanDamme, et al.
Retrovirology|June 17, 2016
Association of mutations in V3/C3 domain with enhanced sensitivity of HIV-1 clade C primary envelopes to autologous broadly neutralizing plasma antibodiesSuprit Deshpande, Shilpa Patil, Rajesh Kumar, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Expert Review of Vaccines|April 25, 2017
A bioinformatics roadmap for the human vaccines projectRichard H Scheuermann, Robert S Sinkovits, Theodore Schenkelberg, et al.
Expert Review of Vaccines|February 13, 2015
Building the Human Vaccines Project: strategic management recommendations and summary report of the 15-16 July 2014 business workshopTheodore Schenkelberg, Marie-Paule Kieny, A E Bianco, et al.
Lancet (London, England)|November 30, 2004
An AIDS vaccine: no time to give upDennis R Burton, Ronald C Desrosiers, Philip R Johnson, et al.
Nature Medicine|June 7, 2008
Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humansDavid I Watkins, Dennis R Burton, Esper G Kallas, et al.
Retrovirology|November 23, 2016
Membrane bound modified form of clade B Env, JRCSF is suitable for immunogen design as it is efficiently cleaved and displays all the broadly neutralizing epitopes including V2 and C2 domain-dependent conformational epitopesSupratik Das, Saikat Boliar, Nivedita Mitra, et al.
Vaccine|March 20, 2016
Status of vaccine research and development of vaccines for HIV-1Jeffrey T Safrit, Patricia E Fast, Lisa Gieber, et al.
Scientific Reports|October 28, 2014
Toward a more accurate view of human B-cell repertoire by next-generation sequencing, unbiased repertoire capture and single-molecule barcodingLinling He, Devin Sok, Parisa Azadnia, et al.
Nature Chemical Biology|July 9, 2013
Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodiesMohammed N Amin, Jason S McLellan, Wei Huang, et al.
Trends in Immunology|April 29, 2020
Improving Vaccine-Induced Immunity: Can Baseline Predict Outcome?John S Tsang, Carlota Dobaño, Pierre VanDamme, et al.
Retrovirology|June 17, 2016
Association of mutations in V3/C3 domain with enhanced sensitivity of HIV-1 clade C primary envelopes to autologous broadly neutralizing plasma antibodiesSuprit Deshpande, Shilpa Patil, Rajesh Kumar, et al.
Pageof 7